Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00596518
What this trial is testing

Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

Who this might be right for
Renal Insufficiency, Chronic
Pfizer 30
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04729582
What this trial is testing

Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients

Who this might be right for
Urinary IncontinenceEpispadias, Male
Simone Spuler, MD 21
Not applicableStudy completedNCT02340689
What this trial is testing

Primary Hyperoxaluria Mutation Genotyping/Phenotyping

Who this might be right for
Primary Hyperoxaluria
Mayo Clinic 1,235
Large-scale testing (Phase 3)Study completedNCT00002990
What this trial is testing

Surgery and BCG in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,288
Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Large-scale testing (Phase 3)Study completedNCT03049735
What this trial is testing

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Who this might be right for
Heavy Menstrual BleedingUterine Fibroid
Myovant Sciences GmbH 388
Post-approval studies (Phase 4)Study completedNCT00583518
What this trial is testing

STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)

Who this might be right for
Postmenopausal Women With Primary Osteoporosis
Nycomed 129
Early research (Phase 1)UnknownNCT00574418
What this trial is testing

Far Infrared Radiation Treatment for Uterine Fibroids

Who this might be right for
Leiomyoma
GAAD Medical Research Institute Inc. 2
Not applicableWithdrawnNCT00849316
What this trial is testing

Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S
Early research (Phase 1)Study completedNCT06039826
What this trial is testing

LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

Who this might be right for
Overweight
Eli Lilly and Company 46
Early research (Phase 1)Study completedNCT03719326
What this trial is testing

Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

Who this might be right for
TNBC - Triple-Negative Breast CancerOvarian Cancer
Arcus Biosciences, Inc. 35
Not applicableStudy completedNCT03751774
What this trial is testing

The MAMAACT Intervention

Who this might be right for
Health LiteracyStillbirthApgar; 0-3 at 1 Minute+2 more
University of Copenhagen 4,153
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT04846920
What this trial is testing

Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)UnknownNCT05151549
What this trial is testing

Carilizumab Combined With Concurrent Chemoradiotherapy

Who this might be right for
Cervical Cancer
Hunan Cancer Hospital 46
Large-scale testing (Phase 3)Ended earlyNCT00441558
What this trial is testing

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

Who this might be right for
Sexual Dysfunctions, Psychological
Sprout Pharmaceuticals, Inc 1,723
Not applicableStudy completedNCT06890208
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 176
Testing effectiveness (Phase 2)UnknownNCT01446484
What this trial is testing

Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

Who this might be right for
End-Stage Renal DiseaseKidney Failure
Pirogov Russian National Research Medical University 30
Large-scale testing (Phase 3)Study completedNCT00172133
What this trial is testing

Open Label Extension Study of PREOS

Who this might be right for
Osteoporosis
Shire 1,683
Next Page